Skip to main content
Basilea Pharmaceutica AG (LON:0QNA)
London flag London · Delayed Price · Currency is GBP · Price in CHF
45.73
+1.05 (2.35%)
Feb 21, 2025, 4:19 PM BST

Basilea Pharmaceutica AG Revenue

In the year 2024, Basilea Pharmaceutica AG had annual revenue of 208.54M CHF with 32.30% growth. Basilea Pharmaceutica AG had revenue of 132.25M in the half year ending December 31, 2024, with 46.75% growth.

Revenue
208.54M CHF
Revenue Growth
+32.30%
P/S Ratio
n/a
Revenue / Employee
1.42M CHF
Employees
147
Market Cap
486.49M GBP

Revenue Chart

* This company reports financials in CHF.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024208.54M50.91M32.30%
Dec 31, 2023157.63M9.87M6.68%
Dec 31, 2022147.77M-357.00K-0.24%
Dec 31, 2021148.12M20.49M16.06%
Dec 31, 2020127.63M-6.75M-5.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
GSK plc 31.38B
Haleon 11.24B
Smith & Nephew 4.46B
Hikma Pharmaceuticals 2.39B
ConvaTec Group 1.74B
HUTCHMED (China) 483.31M
Genus 668.80M
Revenue Rankings

Basilea Pharmaceutica AG News

More News